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thermore, post implementation research is needed to
document the positive effect of vaccination on
nasopharyngeal carriage as well as the overall
reduction in pneumococcal infections, at the commu›
nity level and in risk groups. Since the vaccine is
prepared by a fraction of pathogenic serotypes, an
increase of invasive disease caused by virulent
non›vaccine serotypes could replace that disease elimi›
nated by vaccination. A randomised trial showed that
although this vaccine decreased episodes of otitis
media due to serotypes contained in the vaccine by
57%, episodes due to non›cross reactive serotypes
increased by 33%.10 Thus very careful monitoring of
pneumococcal disease episodes (absolute numbers
and serotypes causing each episode) is necessary, after
any change in strategy.
For healthcare policy makers, cost effectiveness is
another important consideration. A cost benefit analy›
sis in the United States has shown that protein
conjugate pneumococcal vaccine could be cost
effective among healthy infants and children.11
However, the current cost is high enough and many
governments in the Western world are hesitant to pay
for protein conjugate pneumococcal vaccines. For
developing countries, which carry the vast majority of
the global burden of pneumococcal disease, the cost is
prohibitive. Undernourished children worldwide are
probably the group with the highest risk, and they may
continue to remain outside the realm of clinical testing
and use unless cost issues are resolved. Similarly, cost
benefit must also be assessed in elderly and
immunodeficient patients. Clinical studies should cap›
ture deaths from pneumococcal disease, overall
mortality and morbidity, the use of other treatments,
especially antibiotics, and the indirect implications for
potential curtailment of bacterial resistance.
In the era of the global spread of multidrug resist›
ant Streptococcus pneumoniae,12 generating data about
the efficacy of protein conjugate pneumococcal
vaccine from individuals at risk is an important
priority. Both the industry and health authorities
should show interest in undertaking and covering the
cost of randomised trials. In the United Kingdom an
efficacy study among elderly people will begin soon,
sponsored by the Department of Health (N French,
personal communication). If efficacy of the protein
conjugate pneumococcal vaccine is established and the
means are found for its implementation in both devel›
oped and developing countries, the contribution to
health globally could be immense. In contrast, if the
protein conjugate pneumococcal vaccine fails to fulfil
these expectations, other options such as peptide
vaccines may need to be developed to cover the
existing gaps in invasive pneumococcal disease
prevention.
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Global nursing shortages
Are often a symptom of wider health system or societal ailments
In October 2001 government chief nurses and otherdelegates from 66 countries met to discuss how bestto deal with a common challenge—the global
growth of nursing shortages.1 Nursing shortages in the
United Kingdom and elsewhere have been a repetitive
phenomenon, usually due to an increasing demand for
nurses outstripping static or a more slowly growing sup›
ply.2 This time the situation is more serious. Demand
continues to grow, while projections for supply point to
actual reductions in the availability of nurses in some
developed and developing countries. Some health
systems are also coping with the legacy of ill conceived
reform projects of the 1990s, which demotivated and
disenfranchised nurses and other staff.
Developed countries are facing a demographic
double whammy. The United States, United Kingdom,
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Australia, Canada, and other countries have an ageing
nursing workforce, caring for increasing numbers of
elderly people.3–5 The challenge is how to replace the
many nurses who will retire over the decade. Some
countries also have to cope with reductions in
numbers entering the nursing profession. Attractive
alternative opportunities are now available to the
young women who have been the traditional recruits
into the profession.
The crisis of nursing shortage in these countries is
now firmly on the policy agenda, and initiatives are
underway in four main areas.6 Firstly, improving
retention—keeping the scarce nurses already in
employment. Research indicates that nurses are
attracted to work and remain in work because of the
opportunities to develop professionally, to gain
autonomy, and to participate in decision making, while
being fairly rewarded.7 Factors related to work environ›
ment can be crucial,8 and there is some evidence that a
decentralised style of management, flexible employ›
ment opportunities, and access to continuing profes›
sional development can improve both the retention of
nursing staff and patient care.9
Secondly, countries can broaden the recruitment
base. Nursing has often recruited from a narrowly
delineated group of young women. Some countries are
now trying to open out access routes into nursing for a
broader range of recruits, including mature entrants,
entrants from ethnic minorities, and less qualified
entrants who have vocational qualifications or work
based experience.
A third strategy is to attract returners back into the
profession. Most countries have relatively large pools
of former nurses with the necessary qualifications, on
paper at least, to re›enter nursing. They are attractive to
governments because they appear to offer a relatively
quick fix. Nevertheless, attention has to be paid to why
the nurses left the health system in the first place and
what needs to be done to get them back.
A fourth intervention is importing nurses from
other countries. Active international recruitment of
nurses is happening on a large scale as employers from
one country target another country, and recruit 50 or
100 nurses at a time. Developed countries can exploit
push factors, which make some nurses in developing
countries willing to cross national boundaries. These
factors include relatively low pay, poor career
structures, lack of opportunities for further education,
and in some countries, the threat of violence. The eth›
ics of some of these recruitment practices remain open
to question, particularly if a shortage is not being
solved, and is merely being redistributed to a country
less well equipped to deal with it.
The limitation of the above solutions is that they
focus on nursing as the problem. In reality nursing
shortages are often a symptom of wider health system
or societal ailments. Nursing in many countries contin›
ues to be undervalued as women’s work, and nurses are
given only limited access to resources to make them
effective in their jobs and careers. For sustainable solu›
tions other interventions will also be needed. These
should be based on the recognition that health care is
labour intensive and that available nursing resources
must be used effectively. Shortage is not just about
numbers but about how the health system functions to
enable nurses to use their skills effectively.
Many countries need to enhance, reorientate, and
integrate their workforce planning capacity across
occupations and disciplines to identify the skills and
roles needed to meet identified service needs. They can
also improve day to day matching of nurse staffing with
workload. Flexibility should be about using working
patterns that are efficient, but which also support
nurses in maintaining a balance between their work
and personal life.
A wider perspective is needed to achieve clarity of
roles and a better balance of registered nurses,
physicians, other health professionals, and support
workers. The evidence base on skill mix is
developing,10–12 and many studies highlight the scope
for effective deployment of clinical nurse specialists
and nurse practitioners in advanced roles.
Why have these wider reaching interventions not
been more systematically implemented? The very fact
that they have a wider reach means that they often
challenge current practice, health system inertia, and
vested interests. Nursing shortages are then portrayed
as a problem only for nursing. They are not; they are a
health system problem, which undermines health
system effectiveness and requires health system
solutions.
James Buchan professor, social science and health care
Queen Margaret University College, Edinburgh EH12 8TS
jbuchan@qmuc.ac.uk
1 Global nursing partnerships: strategies for a sustainable nursing workforce.
Atlanta: Emory University, 2001. www.nursing.emory.edu
2 Buchan J, Seccombe I, Smith G. Nurses’ work: an analysis of the UK nursing
labour market. Aldershot: Ashgate Press, 1998.
3 Buchan J. Nurse migration and international recruitment. Nurs Inq
2001;8:203›4.
4 Advisory Committee on Health Human Resources, Health Canada. The
nursing strategy for Canada. Ottawa: Health Canada, 2000.
5 Buerhaus P, Staiger D, Auerbach D. Implications of a rapidly aging nurse
workforce. JAMA 2000;283:2948›54.
6 Buchan J. Planning for change: developing a policy framework for nurs›
ing labour markets. Int Nur Rev 2000; 47:199›206.
7 Irvine D, Evans M. Job satisfaction and turnover amongst nurses:
integrating research findings across studies. Nur Res 1995:44:246›53.
8 Baumann A, O’Brien›Pallas L, Armstrong›Stassen M, Blythe J, Bourbon›
nais R, Cameron S, et al. Commitment and care: the benefits of a healthy work›
place for nurses, their patients and the system: Final report. Ottawa: Canadian
Health Service Research Foundation, 2001.
9 Aiken L, Smith H, Lake E. Lower Medicare mortality amongst a set of
hospitals known for good nursing care Med Care 1994;32:771›87.
10 Brown SA, Grimes DE. A meta›analysis of nurse practitioners and nurse
midwives in primary care. Nurs Res 1995;44:332›9.
11 Kinnersley P, Anderson E, Parry K, Clement J, Archard L, Turton P, et al.
Randomised control trial of nurse practitioner versus general
practitioner care for patients requesting same day consultation in
primary care. BMJ 2000;320:1043›8.
12 Buchan J, Ball J, O’May F. If skill mix is the answer, what is the question? J
Health Services Res Policy 2000;16:233›8.
We ask all editorial writers to sign a declaration of competing interests
(bmj.com/guides/confli.shtml#aut). We print the interests only
when there are some. When none are shown, the authors have ticked the
‘‘None declared’’ box.
Editorials
752 BMJ VOLUME 324 30 MARCH 2002 bmj.com
 on 26 May 2006 bmj.comDownloaded from 
